Cargando…

Impact of the COVID‐19 pandemic on recruitment to clinical research studies in rheumatology

Detalles Bibliográficos
Autores principales:	Mirza, Mazin, Siebert, Stefan, Pratt, Arthur, Insch, Elspeth, McIntosh, Frances, Paton, John, Wright, Claire, Buckley, Christopher D., Isaacs, John, McInnes, Iain B., Raza, Karim, Falahee, Marie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242596/ https://www.ncbi.nlm.nih.gov/pubmed/33938621 http://dx.doi.org/10.1002/msc.1561

Ejemplares similares

Patient and researcher perspectives on facilitating patient and public involvement in rheumatology research
por: Pollock, Judith, et al.
Publicado: (2016)

The student patient alliance: development and formative evaluation of an initiative to support collaborations between patient and public involvement partners and doctoral students
por: Simons, Gwenda, et al.
Publicado: (2023)

JAK Inhibitors in Rheumatology: Implications for Paediatric Syndromes?
por: Kerrigan, S. A., et al.
Publicado: (2018)

Number of days required to measure sedentary time and physical activity using accelerometery in rheumatoid arthritis: a reliability study
por: O’Brien, Ciara M., et al.
Publicado: (2023)

JAK inhibitors and infections risk: focus on herpes zoster
por: Sunzini, Flavia, et al.
Publicado: (2020)

Targeting the rheumatoid arthritis synovial fibroblast via cyclin dependent kinase inhibition: An early phase trial
por: Siebert, Stefan, et al.
Publicado: (2020)

TRAFIC: statistical design and analysis plan for a pragmatic early phase 1/2 Bayesian adaptive dose escalation trial in rheumatoid arthritis
por: Cole, M., et al.
Publicado: (2021)

Cutaneous lesions in psoriatic arthritis are enriched in chemokine transcriptomic pathways
por: Johnsson, Hanna, et al.
Publicado: (2023)

Why did IL-23p19 inhibition fail in AS: a tale of tissues, trials or translation?
por: Siebert, Stefan, et al.
Publicado: (2019)

JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
por: Fragoulis, George E, et al.
Publicado: (2019)

Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial
por: Pratt, Arthur G, et al.
Publicado: (2021)

Ankylosing spondylitis patients display altered dendritic cell and T cell populations that implicate pathogenic roles for the IL-23 cytokine axis and intestinal inflammation
por: Wright, Pamela B., et al.
Publicado: (2016)

Rheumatoid arthritis prevention: any takers?
por: Falahee, Marie, et al.
Publicado: (2021)

Perspectives of at-Risk Individuals on Preventive Intervention for Rheumatoid Arthritis: A Mini Review
por: Falahee, Marie, et al.
Publicado: (2022)

Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Naïve Rheumatoid Arthritis
por: Cooles, Faye A. H., et al.
Publicado: (2018)

Leukotrienes, mast cells, and T cells
por: McInnes, Iain B
Publicado: (2003)

Introduction
por: McInnes, Iain B
Publicado: (2003)

T Cell Maturation in Inflammatory Synovitis
por: McInnes, Iain B
Publicado: (2000)

Rheumatology in ICU
por: Raza, Tasleem
Publicado: (2019)

Differential dendritic cell expression in chronic inflammatory arthritis: implications for their maturation, recruitment and involvement in disease
por: Jongbloed, S, et al.
Publicado: (2004)

BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study): protocol for a non-randomised longitudinal cohort study
por: Rayner, Fiona, et al.
Publicado: (2021)

Metabolic Profiling Predicts Response to Anti–Tumor Necrosis Factor α Therapy in Patients With Rheumatoid Arthritis
por: Kapoor, Sabrina R, et al.
Publicado: (2013)

The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases
por: Gabay, Cem, et al.
Publicado: (2009)

Synovial Tissue Response to Treatment in Psoriatic Arthritis
por: Codullo, Veronica, et al.
Publicado: (2011)

Erratum to: Secukinumab: A New Treatment Option for Psoriatic Arthritis
por: Mease, Philip, et al.
Publicado: (2016)

IL-23 orchestrating immune cell activation in arthritis
por: Najm, Aurélie, et al.
Publicado: (2021)

TNF is a homoeostatic regulator of distinct epigenetically primed human osteoclast precursors
por: Ansalone, Cecilia, et al.
Publicado: (2021)

Future therapeutic targets in rheumatoid arthritis?
por: Cheung, Tommy Tsang, et al.
Publicado: (2017)

Immune-mediated inflammatory disease therapeutics: past, present and future
por: McInnes, Iain B., et al.
Publicado: (2021)

Harnessing the small intestinal axis to resolve systemic inflammation
por: Bodmer, Mark, et al.
Publicado: (2022)

Neutropaenia in early rheumatoid arthritis: frequency, predicting factors, natural history and outcome
por: Fragoulis, George E, et al.
Publicado: (2018)

Teaching Rheumatology
por: Davis, John A.
Publicado: (1992)

Characteristics of rheumatoid arthritis and its association with major comorbid conditions: cross-sectional study of 502 649 UK Biobank participants
por: Siebert, Stefan, et al.
Publicado: (2016)

Depression and anxiety in an early rheumatoid arthritis inception cohort. associations with demographic, socioeconomic and disease features
por: Fragoulis, George E, et al.
Publicado: (2020)

CTSA recruitment resources: An inventory of what CTSA hubs are currently offering
por: Niyibizi, Nyiramugisha, et al.
Publicado: (2020)

Patient and public involvement in an international rheumatology translational research project: an evaluation
por: de Souza, Savia, et al.
Publicado: (2022)

Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases?
por: McCarey, David W, et al.
Publicado: (2005)

Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities
por: Mehta, Puja, et al.
Publicado: (2020)

Guía para el desarrollo del niño sordociego /
por: McInnes, J. M. (John M.)
Publicado: (1994)

Interleukin-18: a therapeutic target in rheumatoid arthritis?
por: McInnes, Iain B, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_4gdrqe39dmagelbpu7b0j666n2